- AU$4.31m
- -AU$6.39m
- $1.22m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.25 | ||
Price to Tang. Book | 0.41 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 2.26 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -139.36% | ||
Return on Equity | -138.72% | ||
Operating Margin | -1287.73% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1.52 | 1.84 | 0.9 | 0.56 | 1.22 | n/a | n/a | -5.23% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Enlitic, Inc. is a healthcare information technology (IT) company that uses Artificial Intelligence (AI) to expand capacity and improve clinical workflows and create a foundation for a real-world evidence medical image database for healthcare providers. It is focused on developing tools that solve longstanding challenges in radiology rather than developing point solutions that exacerbate the issues radiology faces. Its products include ENDEX, ENCOG, ENCODE, and ENSIGHT. ENDEX transforms new and historical medical image data descriptions to a consistent, clinically relevant standard nomenclature that impacts workflows and capacity within and beyond radiology. ENCOG deidentifies and anonymizes imaging data to remove PHI from pixel data, metadata, and private tags while retaining clinically relevant information.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 22nd, 2014
- Public Since
- December 19th, 2023
- No. of Shareholders
- 555
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 86,273,032

- Address
- 2510 East Harmony Rd., Suite 202, FORT COLLINS, 80528
- Web
- https://www.enlitic.com/
- Phone
- +1 3026587581
- Auditors
- RSM AUSTRALIA PTY LTD
Upcoming Events for ENL
Similar to ENL
3P Learning
Australian Stock Exchange - SEATS
5G Networks
Australian Stock Exchange - SEATS
8Common
Australian Stock Exchange - SEATS
ActivePort
Australian Stock Exchange - SEATS
Adisyn
Australian Stock Exchange - SEATS
FAQ
As of Today at 20:27 UTC, shares in Enlitic are trading at AU$0.05. This share price information is delayed by 15 minutes.
Shares in Enlitic last closed at AU$0.05 and the price had moved by -91.67% over the past 365 days. In terms of relative price strength the Enlitic share price has underperformed the ASX All Ordinaries Index by -91.97% over the past year.
There is no consensus recommendation for this security.
Find out moreEnlitic does not currently pay a dividend.
Enlitic does not currently pay a dividend.
Enlitic does not currently pay a dividend.
To buy shares in Enlitic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.05, shares in Enlitic had a market capitalisation of AU$4.31m.
Here are the trading details for Enlitic:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ENL
Based on an overall assessment of its quality, value and momentum Enlitic is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Enlitic. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -15.68%.
As of the last closing price of AU$0.05, shares in Enlitic were trading -52.4% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Enlitic PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Enlitic's directors